AI assistant
Sending…
Protara Therapeutics, Inc. — Director's Dealing 2020
Feb 11, 2020
34057_dirs_2020-02-11_cb0d6609-5625-4307-bdf1-dfa62a5a69ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ArTara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2020-02-11
Reporting Person: Davis Blaine (Chief Financial Officer)
More from Protara Therapeutics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 13
Interim / Quarterly Report
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 24
Capital/Financing Update
2026
Feb 2
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27